Tilray | TRLY - Ebit

金融业

USD 4.15

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 3.15B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	Ebit	更改		日
Acasti Pharma	USD -3.7M		1.13M	2024-12
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -952K		60K	2026-06
Aurora Cannabis	CAD -3.17M		10.29M	2026-06
Avita Medical	AUD -6.17M		4.22M	2026-06
Canopy Growth	CAD -2.03M		143.62M	2026-06
Cronos Group	USD 7.6M		9.06M	2026-06
Dianthus Therapeutics	USD -61.48M		14.95M	2026-06
Divis Laboratories Ltd	INR 11.29B		3.15B	2026-06
Ionis Pharmaceuticals	USD -102.29M		15.71M	2026-06
IQVIA Holdings	USD 608M		1.99B	2026-09
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Moderna	USD -815M		573M	2026-06
Organigram Holdings	CAD 5.33M		15.12M	2026-06
Organon & Co	USD 377M		86M	2026-09
Revvity	USD 124.63M		1.51M	2026-09
Tectonic Therapeutic	USD -24.22M		3.08M	2026-06
Tilray	USD -20.01M		9.34M	2025-09
Viatris	USD 73.7M		93.9M	2026-06
Xeris Pharmaceuticals	USD -24.15M		33.27M	2026-06
Zealand Pharma A/S	-389M		318.05M	2026-03